I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
FDA-approved drug screen identifies proteasome as a synthet..:
Wang, Jingchao
;
Jiang, Jue
;
Chen, Hui
...
Oncogene. 38 (2019) 41 - p. 6737-6751 , 2019
Link:
https://doi.org/10.1038/s41388-019-0912-5
RT Journal T1
FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1038_s41388-019-0912-5&Exemplar=1&LAN=DE A1 Wang, Jingchao A1 Jiang, Jue A1 Chen, Hui A1 Wang, Liyuan A1 Guo, Hao A1 Yang, Likun A1 Xiao, Daibiao A1 Qing, Guoliang A1 Liu, Hudan PB Springer Science and Business Media LLC YR 2019 SN 0950-9232 SN 1476-5594 JF Oncogene VO 38 IS 41 SP 6737 OP 6751 LK http://dx.doi.org/https://doi.org/10.1038/s41388-019-0912-5 DO https://doi.org/10.1038/s41388-019-0912-5 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)